382 unknown, 150 completed, 147 recruiting, 101 not yet recruiting. 233 Not applicable, 190 Phase 2, 69 Phase 3, 51 Phase 4, 48 Phase 1.
Follow Peking University People's Hospital: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Weight Management on AMPK Activation in the Adjunctive Treatment of Endometrial Cancer DEAR-Based Comprehensive Weight Management, Balanced Diet and Self-Directed Exercise - Endometrial Cancer | Not applicable | Not yet recruiting | Peking University People's Hospital | 160 | 2027-01-01 | 2026-10-16 |
| ADC Based Therapy Accroding to HER2 Heterogeneous HER2 target therapy - Breast Cancer (Early Breast Cancer) | Phase 2 | Not yet recruiting | Peking University People's Hospital | 88 | 2027-01-01 | 2026-10-02 |
| MRD-Guided Aumolertinib-Based Adjuvant Therapy for Resected EGFR-Mutant NSCLC Aumolertinib, Pemetrexed, Carboplatin - Non-Small Cell Lung Cancer | Not applicable | Not yet recruiting | Peking University People's Hospital | 50 | 2026-11-01 | 2026-10-14 |
| A Prospective, Open-label, Randomized Trial Comparing Switch to A1811 Versus Continued THP Neoadjuvant Therapy After THP Induction in HER2-Positive Breast Cancer A1811, THP - Breast Cancer (Early Breast Cancer) | Not applicable | Not yet recruiting | Peking University People's Hospital | 432 | 2026-11-01 | 2026-09-28 |
| MRD and Imaging Guided Adaptive Neoadjuvant Therapy for Resectable NSCLC PD-1 inhibitor, Carboplatin, Nab-paclitaxel - Non-Small Cell Lung Cancer (NSCLC) | Phase 2 | Not yet recruiting | Peking University People's Hospital | 100 | 2026-11-01 | 2026-10-21 |
| Prospective ctDNA Testing in Large B-Cell Lymphoma Standard-of-care first-line immunochemotherapy containing an anti-CD20 monoclonal antibody and an anthracycline, such as R-CHOP, Pola-R-CHP, or DA-EPOCH-R. - Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell Lymphoma | Recruiting | Peking University People's Hospital | 100 | 2026-10-15 | 2026-10-16 | |
| Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNI Sirolimus, Ruxolitinib, MMF - Acute Leukemia, Myelodysplastic Syndromes | Phase 1 / Phase 2 | Not yet recruiting | Peking University People's Hospital | 40 | 2026-10-01 | 2026-09-09 |
| Belumosudil Versus Ruxolitinib for Steroid-Refractory or Breakthrough Hepatic cGVHD Ruxolitinib treatment, Belumosudil treatment, Belumosudil Switch to Ruxolitinib - Hematopoietic Stem Cell Transplantation (HSCT), cGVHD | Not applicable | Recruiting | First Affiliated Hospital of Zhejiang University | 170 | 2026-10-01 | 2026-08-31 |
| NAC for Hematopoietic Recovery in Low/Intermediate-Risk AML After CR: A Randomized Controlled Study N-acetyl-L-cysteine (NAC) - Acute Myeloid Leukemia, Adult | Not applicable | Not yet recruiting | Peking University People's Hospital | 180 | 2026-10-01 | 2026-10-09 |
| Prophylactic NAC to Improve Platelet Engraftment After Haploidentical Transplantation in Severe Aplastic Anemia Patients N-acetylcysteine - Aplastic Anemia | Phase 3 | Not yet recruiting | Peking University People's Hospital | 142 | 2026-09-30 | 2026-09-16 |
| Thiotepa-Based Conditioning for Haploidentical Hematopoietic Stem Cell Transplantation in Older Patients With Severe Aplastic Anemia Thiotepa - Severe Aplastic Anemia, Hematopoietic Cell Transplant | Not yet recruiting | Peking University People's Hospital | 20 | 2026-09-20 | 2026-09-21 | |
| The Effect of Different Delivery Positions on Pelvic Floor Function. Lithotomy position, Lateral Position, Upright Position - Stress Urinary Incontinence (SUI) | Not applicable | Not yet recruiting | Peking University People's Hospital | 1992 | 2026-09-20 | 2026-09-10 |
| ED50/ED90 of Phenylephrine Infusion for Preventing Spinal Anesthesia-Induced Hypotension: Supine vs Left-Tilt 15° Phenylephrine hydrochloride infusion - Hypotension After Spinal Anesthesia | Phase 4 | Not yet recruiting | Peking University People's Hospital | 200 | 2026-09-20 | 2026-09-17 |
| Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With Albuminuria Finerenone, Finerenone Placebo, Semaglutide - Obesity; Chronic Kidney Disease; Albuminuria | Not applicable | Not yet recruiting | Peking University People's Hospital | 266 | 2026-09-01 | 2026-09-30 |
| Corticotropin for Behçet's Disease: A Multicenter Randomized Controlled TrialAcronym. Repository Corticotropin Injection (ACTH), Study-matched inactive placebo injection, also called control injection - Behçet's Syndrome, Behçet's Syndrome (BS) | Phase 2 | Not yet recruiting | Peking University People's Hospital | 60 | 2026-09-01 | 2026-09-22 |
| Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis Telitacicept 160mg, Standard therapy - Difficult-to-treat Rheumatoid Arthritis, Rheumatoid Arthritis | Phase 2 | Recruiting | Peking University People's Hospital | 420 | 2026-09-01 | 2026-09-01 |
| VAAPS Combined With Loose Seton Drainage for Postoperative Self-Care: A Prospective Single-Arm Cohort Study VAAPS with Loose Seton Drainage - Pilonidal Sinus Disease | Not applicable | Recruiting | Peking University People's Hospital | 50 | 2026-09-01 | 2026-10-07 |
| Endotracheal Tube Intolerance and Respiratory Airflow Perception Coughing Responses at Tracheal Extubation, Breathing Patterns | Not yet recruiting | Peking University People's Hospital | 224 | 2026-09-01 | 2026-08-12 | |
| Effect of Inspired Oxygen Concentration on Postoperative Atelectasis After VATS Lobectomy Low inspired oxygen concentration (FiO₂=50%) during one-lung ventilation, High inspired oxygen concentration (FiO₂=100%) during one-lung ventilaion - Atelectasis, Postoperative Pulmonary Complications | Not applicable | Not yet recruiting | Peking University People's Hospital | 100 | 2026-09-01 | 2026-08-19 |
| Efficacy and Safety of Low-Dose IL-2 in Neuromyelitis Optica Spectrum Disorder Placebo, IL-2 (interleukin 2) - Neuromyelitis Optica Spectrum Disorder (NMOSD) | Phase 2 | Not yet recruiting | Peking University People's Hospital | 60 | 2026-08-30 | 2026-09-09 |
Showing 20 of 825. Sign in to see all of them.
Purpura, Thrombocytopenic, Idiopathic (49) · Breast Neoplasms (30) · Carcinoma, Non-Small-Cell Lung (29) · Lung Neoplasms (27) · Osteosarcoma (27) · Leukemia, Myeloid, Acute (24) · Endometrial Neoplasms (21) · Neoplasm, Residual (18) · Myelodysplastic Syndromes (16) · Recurrence (14) · Arthritis, Rheumatoid (12) · Multiple Myeloma (12) · Osteoarthritis, Knee (12) · Anemia, Aplastic (11) · Colorectal Neoplasms (11)
Cyclophosphamide (21) · Dexamethasone (18) · Busulfan (17) · Interleukin-2 (17) · Decitabine (12) · Tretinoin (11) · fludarabine (11) · Danazol (10) · Acetylcysteine (9) · Neoadjuvant Therapy (9) · Cisplatin (7) · Etoposide (7) · Prednisone (7) · aldesleukin (7) · apatinib (7)
China (675) · Australia (1) · Canada (1) · Germany (1) · India (1) · Italy (1) · Malaysia (1) · Singapore (1) · South Korea (1) · United Kingdom (1) · United States (1)
Qifa Liu (21) · Xiao-Hui Zhang, MD (16) · Zhanguo Li (16) · Xiaohui Zhang, MD (12) · Jianhao Lin, MD (10) · Jun Wang, M.D. (9) · Xiao-Jun Huang (9) · Qifa Liu, MD (8) · Xiao-Jun Huang, MD (8) · Jin Lu (6) · Xiaojun Huang (6) · Fan Yang, MD (4) · Jiaan Zhu, Dr (4) · Jianliu Wang, Professor (4) · Jin Lu, M.D. (4)
PMID 33460002, PMID 12094370, PMID 14645423, PMID 21826194, PMID 29093181, PMID 30274985, PMID 31015207, PMID 31537547, PMID 31934936, PMID 32103499, PMID 32164760, PMID 32615108, PMID 33453089, PMID 33465704, PMID 33538338, PMID 33687069, PMID 33718234, PMID 34843068, PMID 35154096, PMID 35467818, PMID 37341189, PMID 38954871, PMID 39373164, PMID 10197236, PMID 10446825, PMID 10636102, PMID 11215292, PMID 11604419, PMID 12032772, PMID 12522257, PMID 12949711, PMID 1382099, PMID 1410755, PMID 14515284, PMID 14722039, PMID 14987462, PMID 15364779, PMID 15654796, PMID 15788779, PMID 15928335, PMID 16153272, PMID 16333078, PMID 16440706, PMID 1646585, PMID 16551858, PMID 16624552, PMID 16947627, PMID 17046465, PMID 17062241, PMID 17574838